REDUCEDT+30
Bridgebio Oncology Therapeut · NASDAQ
−126 sh · $496
Filed 5 Oct 2026SEC Form 4view source
- REDUCEDT+30
Bridgebio Oncology Therapeut · NASDAQ
−203 sh · $1.1K
Filed 14 Sept 2026SEC Form 4view source - ACQUIREDT+30
Bridgebio Oncology Therapeut · NASDAQ
+9,038 sh
Filed 14 Sept 2026SEC Form 4view source